The objective is to compare a reduced stent strategy based on drug-coated balloon (DCB) percutaneous coronary intervention (PCI) with conventional drug-eluting stent (DES) coronary revascularization in patients presenting with ST-segment myocardial infarction (STEMI).
Randomization will be performed after successful culprit-lesion guidewire crossing and flow restoration. Random allocation in a 1:1 fashion to one of the following strategies:
* Study group: reduced stent PCI strategy (DCB-based) * Control group: conventional PCI strategy (DES-based).
None
Life expectancy <1 year due 1 to non-cardiac disease.
Inability to provide informed consent.
Cardiogenic shock.
Left ventricular ejection fraction <15%.
Hospital Universitario La Fe
Lead sponsor
ERA4Health
Collaborator